Stephen Safe

1.4k total citations
13 papers, 1.2k citations indexed

About

Stephen Safe is a scholar working on Health, Toxicology and Mutagenesis, Genetics and Cancer Research. According to data from OpenAlex, Stephen Safe has authored 13 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Health, Toxicology and Mutagenesis, 8 papers in Genetics and 6 papers in Cancer Research. Recurrent topics in Stephen Safe's work include Estrogen and related hormone effects (8 papers), Toxic Organic Pollutants Impact (8 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Stephen Safe is often cited by papers focused on Estrogen and related hormone effects (8 papers), Toxic Organic Pollutants Impact (8 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Stephen Safe collaborates with scholars based in United States, Netherlands and Sweden. Stephen Safe's co-authors include Ichen Chen, Leonard F. Bjeldanes, Lisa B. Biegel, Matthew Stoner, Thu Annelise Nguyen, Debie J. Hoivik, Jeong‐Eun Lee, Roger Smith, Brad Saville and Mark Wormke and has published in prestigious journals such as FEBS Letters, Archives of Biochemistry and Biophysics and Biochemical Pharmacology.

In The Last Decade

Stephen Safe

13 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Safe United States 12 523 441 438 209 174 13 1.2k
Andrew McDougal United States 13 282 0.5× 378 0.9× 220 0.5× 149 0.7× 118 0.7× 17 908
Deodutta Roy United States 15 375 0.7× 365 0.8× 407 0.9× 285 1.4× 138 0.8× 20 1.1k
Barbara C. Spink United States 16 399 0.8× 317 0.7× 464 1.1× 250 1.2× 207 1.2× 20 1.1k
Chunhua Qin United States 19 391 0.7× 181 0.4× 749 1.7× 271 1.3× 163 0.9× 26 1.3k
Mark Wormke United States 18 890 1.7× 656 1.5× 854 1.9× 426 2.0× 298 1.7× 19 1.9k
Mikael Gillner Sweden 15 249 0.5× 348 0.8× 354 0.8× 211 1.0× 77 0.4× 23 1.1k
Charles Martucci United States 13 699 1.3× 156 0.4× 456 1.0× 109 0.5× 232 1.3× 21 1.3k
Markus R. Probst United States 17 172 0.3× 652 1.5× 637 1.5× 524 2.5× 104 0.6× 20 1.6k
Kimberly P. Miller United States 15 186 0.4× 440 1.0× 306 0.7× 182 0.9× 77 0.4× 18 1.0k
Debie J. Hoivik United States 14 387 0.7× 170 0.4× 530 1.2× 178 0.9× 252 1.4× 25 1.1k

Countries citing papers authored by Stephen Safe

Since Specialization
Citations

This map shows the geographic impact of Stephen Safe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Safe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Safe more than expected).

Fields of papers citing papers by Stephen Safe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Safe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Safe. The network helps show where Stephen Safe may publish in the future.

Co-authorship network of co-authors of Stephen Safe

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Safe. A scholar is included among the top collaborators of Stephen Safe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Safe. Stephen Safe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Yoon, Kyungsil, et al.. (2001). Differential activation of wild-type and variant forms of estrogen receptor α by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements. The Journal of Steroid Biochemistry and Molecular Biology. 78(1). 25–32. 38 indexed citations
2.
Safe, Stephen. (2001). Transcriptional activation of genes by 17β-estradiol through estrogen receptor-Sp1 interactions. Vitamins and hormones. 62. 231–252. 354 indexed citations
3.
Wormke, Mark, Matthew Stoner, Brad Saville, & Stephen Safe. (2000). Crosstalk between estrogen receptor α and the aryl hydrocarbon receptor in breast cancer cells involves unidirectional activation of proteasomes. FEBS Letters. 478(1-2). 109–112. 91 indexed citations
4.
Nguyen, Thu Annelise, Debie J. Hoivik, Jeong‐Eun Lee, & Stephen Safe. (1999). Interactions of Nuclear Receptor Coactivator/Corepressor Proteins with the Aryl Hydrocarbon Receptor Complex. Archives of Biochemistry and Biophysics. 367(2). 250–257. 116 indexed citations
5.
Letcher, Robert J., Ineke van Holsteijn, Henk‐Jan Drenth, et al.. (1999). Cytotoxicity and Aromatase (CYP19) Activity Modulation by Organochlorines in Human Placental JEG-3 and JAR Choriocarcinoma Cells. Toxicology and Applied Pharmacology. 160(1). 10–20. 55 indexed citations
6.
Wang, Weili, Roger Smith, & Stephen Safe. (1998). Aryl Hydrocarbon Receptor-Mediated Antiestrogenicity in MCF-7 Cells: Modulation of Hormone-Induced Cell Cycle Enzymes. Archives of Biochemistry and Biophysics. 356(2). 239–248. 69 indexed citations
7.
Santostefano, Michael J., et al.. (1996). Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. Biochemical Pharmacology. 51(8). 1077–1087. 61 indexed citations
8.
Hanneman, William H., Marie E. Legare, Rola Barhoumi, et al.. (1996). Stimulation of calcium uptake in cultured rat hippocampal neurons by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology. 112(1). 19–28. 76 indexed citations
9.
Chen, Ichen, Stephen Safe, & Leonard F. Bjeldanes. (1996). Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. Biochemical Pharmacology. 51(8). 1069–1076. 184 indexed citations
10.
Wang, Xiaohong, et al.. (1996). Inhibition of Prolactin Receptor Gene Expression by 2,3,7,8-Tetrachlorodibenzo-p-dioxin in MCF-7 Human Breast Cancer Cells. Archives of Biochemistry and Biophysics. 332(1). 35–40. 24 indexed citations
11.
Fernández, Patricia, et al.. (1994). High passage T47D human breast cancer cells: altered endocrine and 2,3,7,8-tetrachlorodibenzo-p-dioxin responsiveness. European Journal of Pharmacology Environmental Toxicology and Pharmacology. 270(1). 53–65. 13 indexed citations
12.
Xiao-hong, Wang, Rhonda J. Rosengren, V. Morrison, Michael J. Santostefano, & Stephen Safe. (1992). Characterization of the aryl hydrocarbon receptor in the human C-4II cervical squamous carcinoma cell line. Biochemical Pharmacology. 43(7). 1635–1642. 11 indexed citations
13.
Biegel, Lisa B. & Stephen Safe. (1990). Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on cell growth and the secretion of the estrogen-induced 34-, 52- and 160-kDa proteins in human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 37(5). 725–732. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026